224 related articles for article (PubMed ID: 16709607)
1. Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice.
den Boer MA; Voshol PJ; Schröder-van der Elst JP; Korsheninnikova E; Ouwens DM; Kuipers F; Havekes LM; Romijn JA
Endocrinology; 2006 Oct; 147(10):4553-8. PubMed ID: 16709607
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.
Wiedemann MS; Wueest S; Item F; Schoenle EJ; Konrad D
Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E388-95. PubMed ID: 23736545
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies.
Haluzik M; Gavrilova O; LeRoith D
Endocrinology; 2004 Apr; 145(4):1662-7. PubMed ID: 14670996
[TBL] [Abstract][Full Text] [Related]
5. Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1 promotes diet-induced hepatic steatosis and insulin resistance.
Xu E; Dubois MJ; Leung N; Charbonneau A; Turbide C; Avramoglu RK; DeMarte L; Elchebly M; Streichert T; Lévy E; Beauchemin N; Marette A
Endocrinology; 2009 Aug; 150(8):3503-12. PubMed ID: 19406938
[TBL] [Abstract][Full Text] [Related]
6. Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation.
Hoy AJ; Bruce CR; Turpin SM; Morris AJ; Febbraio MA; Watt MJ
Endocrinology; 2011 Jan; 152(1):48-58. PubMed ID: 21106876
[TBL] [Abstract][Full Text] [Related]
7. Energy-restricted high-fat diets only partially improve markers of systemic and adipose tissue inflammation.
Kalupahana NS; Voy BH; Saxton AM; Moustaid-Moussa N
Obesity (Silver Spring); 2011 Feb; 19(2):245-54. PubMed ID: 20847734
[TBL] [Abstract][Full Text] [Related]
8. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
9. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity.
Di Gregorio GB; Hensley L; Lu T; Ranganathan G; Kern PA
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E182-7. PubMed ID: 15191885
[TBL] [Abstract][Full Text] [Related]
10. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
11. Chronic prednisolone treatment aggravates hyperglycemia in mice fed a high-fat diet but does not worsen dietary fat-induced insulin resistance.
Laskewitz AJ; van Dijk TH; Grefhorst A; van Lierop MJ; Schreurs M; Bloks VW; Reijngoud DJ; Dokter WH; Kuipers F; Groen AK
Endocrinology; 2012 Aug; 153(8):3713-23. PubMed ID: 22653558
[TBL] [Abstract][Full Text] [Related]
12. High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.
Li L; Yang G; Li Q; Tang Y; Li K
Ann Nutr Metab; 2006; 50(6):499-505. PubMed ID: 17191023
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.
Basciano H; Miller AE; Naples M; Baker C; Kohen R; Xu E; Su Q; Allister EM; Wheeler MB; Adeli K
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E462-73. PubMed ID: 19509184
[TBL] [Abstract][Full Text] [Related]
14. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.
Parlevliet ET; de Leeuw van Weenen JE; Romijn JA; Pijl H
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E318-24. PubMed ID: 20530733
[TBL] [Abstract][Full Text] [Related]
15. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
16. A fish oil diet does not reverse insulin resistance despite decreased adipose tissue TNF-alpha protein concentration in ApoE-3*Leiden mice.
Muurling M; Mensink RP; Pijl H; Romijn JA; Havekes LM; Voshol PJ
J Nutr; 2003 Nov; 133(11):3350-5. PubMed ID: 14608043
[TBL] [Abstract][Full Text] [Related]
17. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
Popov VB; Jornayvaz FR; Akgul EO; Kanda S; Jurczak MJ; Zhang D; Abudukadier A; Majumdar SK; Guigni B; Petersen KF; Manchem VP; Bhanot S; Shulman GI; Samuel VT
FASEB J; 2016 Mar; 30(3):1207-17. PubMed ID: 26644352
[TBL] [Abstract][Full Text] [Related]
18. SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice.
Zadjali F; Santana-Farre R; Vesterlund M; Carow B; Mirecki-Garrido M; Hernandez-Hernandez I; Flodström-Tullberg M; Parini P; Rottenberg M; Norstedt G; Fernandez-Perez L; Flores-Morales A
FASEB J; 2012 Aug; 26(8):3282-91. PubMed ID: 22562833
[TBL] [Abstract][Full Text] [Related]
19. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.
Bouter B; Geary N; Langhans W; Asarian L
Metabolism; 2010 Jul; 59(7):1065-73. PubMed ID: 20045154
[TBL] [Abstract][Full Text] [Related]
20. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
